Cellosaurus HeLa-EM2-11ht (CVCL_WN71)
| Cell line name | HeLa-EM2-11ht |
|---|---|
| Synonyms | HeLa EM2-11ht |
| Accession | CVCL_WN71 |
| Resource Identification Initiative | To cite this cell line use: HeLa-EM2-11ht (RRID:CVCL_WN71) |
| Comments | Population: African American. Characteristics: Stably expresses an improved version of the reverse tetracycline controlled transactivator (rtTA2S-M2) under the control of the human EF1a promoter. Also express an hygromycin B phosphotransferase-thymidine kinase (HygTk) fusion gene as a positive/negative selection marker. Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR). Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK. Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18). Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. |
| Disease | Human papillomavirus-related cervical adenocarcinoma (NCIt: C27677) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_0030 (HeLa) |
| Sex of cell | Female |
| Age at sampling | 30Y6M |
| Category | Cancer cell line |
| Publications | PubMed=19264799; DOI=10.1093/nar/gkp108; PMCID=PMC2673444 |
| Cross-references | |
| Encyclopedic resources | Wikidata; Q94100654 |
| Entry history | |
| Entry creation | 24-May-2019 |
| Last entry update | 10-Sep-2024 |
| Version number | 8 |